How many versions of evantumumab are there? How to buy?

Evantumumab is a bispecific antibody that targets the EGFR and MET receptors and is used to treat certain types of non-small cell lung cancer (NSCLC). Due to its targeted therapeutic properties, evantumumab has received widespread attention worldwide. However, regarding the generic version of evantumumab and how to purchase it, current information shows that there is no officially authorized generic version on the market.

Evantuzumab versions and purchase methods

is an original drug developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Currently, there is only the version produced by this company on the market. The medicine is available in a pack of 350 mg/7 ml. For domestic patients, since evantumumab has not been officially approved for marketing in China, if patients need to use it, they may need to purchase it overseas.

1. Drug version: Evantumumab produced by Janssen Pharmaceuticals in the United States. A box sells for about $10,300, and the drug specification is 350mg/7ml. Other versions are not yet available.

2. Purchase method: Since evantumumab has not yet been officially launched in China and is only available in Taiwan and Hong Kong, patients in mainland China cannot obtain the drug directly from formal medical institutions such as hospitals or pharmacies. Some medical service institutions or multinational medical platforms may provide purchase services for evantumumab, and patients in need can make relevant consultations to learn about formal purchase channels.

3. Precautions when purchasing drugs: Purchasing generic evantumumab requires comprehensive consideration of legal, safety, economic and efficacy factors. Before deciding to purchase, patients must work closely with medical professionals to choose the most appropriate way to ensure the smooth progress of treatment. After purchasing the medicine, you should use it under the guidance of a doctor. Do not adjust the dosage without permission. The medicine needs to be refrigerated and stored at 2°C-8°C.

Warm reminder: Since evantumumab has not yet been approved in China, patients need to understand the relevant laws and regulations to ensure that they purchase the drug through legal channels. Before purchasing the drug, patients should consult a professional oncologist to understand whether their condition is suitable for the use of evantumumab and obtain a doctor's prescription. Patients can pay close attention to the launch progress of evantumumab in China. Once the drug is approved for marketing, it will provide domestic patients with a more convenient way to purchase it.